Seizing The Day: How Coronavirus Breaks Then Makes Vaccine Makers In China

 
• By Brian Yang

Amid fears of a second wave of coronavirus infections and the increasing dominance of state-owned enterprises, private vaccine makers in China are struggling to make the best of the outbreak, BravoVax CEO Ke Wu tells Scrip in an exclusive interview.

Beijing_Queue_Testing
BRAVOVAX SEES CHALLENGES FOR SMALL VACCINE DEVELOPERS IN CHINA WHERE MASS TESTING IS UNDERWAY • Source: Shutterstock

More from COVID-19

More from Scrip